RecallDepth
Class II Terminated

Tadalafil Tablets, USP, 2.5 mg Rx Only, Packaged as: a) 30-count bottle NDC 16729-369-10, UPC 3 16729 36910 7; b) 500-count bottle NDC 16729-369-16, UPC 3 16729 36916 9; Manufactured for: Accord Healthcare, Inc., Durham, NC 27703. Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213 INDIA

Company
Accord Healthcare, Inc.
Recall Initiated
February 7, 2023
Posted
March 8, 2023
Recall Number
D-0414-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
36,773 bottles
Firm Location
Durham, NC, United States

Reason for Recall

CGMP Deviations: recalling drug products following an FDA inspection.

Distribution

United States including Puerto Rico and Canada

Lot / Code Info

Batches: a) P2002522, Exp. Date 4/30/2023; P2005817, P2005816, Exp. Date 10/31/2023; P2203687, Exp. Date 6/30/2025; b) P2002521, Exp. Date 4/30/2023; P2005818, Exp. Date 10/31/2023; P2100075, Exp. Date 12/31/2023; P2100996, P2100997, P2100998, P2100999, Exp. Date 1/31/2024;

More recalls by Accord Healthcare, Inc.

View all recalls by this company →

Other recent Class II Drug recalls